Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Albany Molecular Research, Inc.    AMRI

ALBANY MOLECULAR RESEARCH, INC. (AMRI)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesNewsCompany 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Company
Albany Molecular Research, Inc. is a research and manufacturing organization, which provides drug discovery, development, and manufacturing services.It operates through three segments: Discovery and Development Services, Active Pharmaceutical Ingredients (API), Drug Product and Fine Chemical.The... 
More about the company
Latest news on ALBANY MOLECULAR RESEARCH,
01/17ALBANY MOLECULAR RESEARCH : AMRI Experts to Lead Discussion on Bringing a Medica..
PU
01/04ALBANY MOLECULAR RESEARCH : AMRI Names Michael Mulhern as Chief Executive Office..
PU
2017ALBANY MOLECULAR RESEARCH : AMRI’s SSCI Implements Next-Generation Analyti..
PU
2017ALBANY MOLECULAR RESEARCH : AMRI Doubles Bulk API Aseptic Manufacturing Capacity
PU
2017ALBANY MOLECULAR RESEARCH : AMRI Presents Expanded Capabilities at 2017 AAPS Ann..
PU
2017ALBANY MOLECULAR RESEARCH : AMRI to Exhibit and Present at MD&M Minneapolis 2017
PU
2017ALBANY MOLECULAR RESEARCH : AMRI Appoints Paul Feuerman as Senior Vice President..
PU
2017ROBBINS GELLER RUDMAN & DOWD LLP : Files Class Action Suit against Albany Molecu..
BU
2017ALBANY MOLECULAR RESEARCH : AMRI to Highlight Sterile Manufacturing Capacity Exp..
PU
2017ALBANY MOLECULAR RESEARCH : AMRI Launches Stand-Alone Service; Expanding Solutio..
PU
More news
Sector news : Biotechnology & Medical Research - NEC
06/20GILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
06/20Roche to Buy Rest of Cancer Firm -- WSJ
DJ
06/20Latecomer Sanofi looks to catch next wave of cancer therapies
RE
06/19Alexion Uses FDA Priority-Review Voucher for Blood Disorder
DJ
06/19Roche to Pay $2.4 Billion for Full Control of Foundation Medicine -- 2nd Upda..
DJ
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
02/21Bruker finance chief bids adieu 
2017Control4 up 4.4% on move into S&P SmallCap 600 
2017Stocks to watch next week 
2017Premarket analyst action - healthcare 
2017Premarket analyst action - healthcare 
Managers
NameTitle
Michael J. Mulhern Chief Executive Officer & Director
George Svokos Chief Operating Officer
Anthony L. Mattacchione Chief Financial Officer & Senior Vice President
Jimmy Z. Wang Chief Information Officer & Senior Vice President
Lori M. Henderson Secretary, Senior Vice President & General Counsel
Sector and Competitors
1st jan.Capitalization (M$)
ALBANY MOLECULAR RESEARCH, INC.0.00%0
CELLTRION, INC.--.--%33 349
IQVIA HOLDINGS INC6.07%21 424
LONZA GROUP3.53%20 530
INCYTE CORPORATION-22.94%15 692
SEATTLE GENETICS, INC.24.95%10 577